A. R. Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
as on 21-06-2024
- Paid Up Capital ₹ 3.50 Cr
as on 21-06-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 71.88 Cr
as on 21-06-2024
- Satisfied Charges ₹ 16.50 Cr
as on 21-06-2024
- Revenue -14.95%
(FY 2022)
- Profit 9.12%
(FY 2022)
- Ebitda 2.89%
(FY 2022)
- Net Worth 29.02%
(FY 2022)
- Total Assets 17.99%
(FY 2022)
About A. R. Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹71.88 Cr. The company has closed loans amounting to ₹16.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kallam Chaitanya and Kallam Subbareddy serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC055235
- Company No.
055235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does A. R. Life Sciences Private Limited offer?
A. R. Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Antipyretic and Analgesic API, Anti Infective API, Brain & Nervous System Drugs, Antimigraine Drug, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Nervous System and Antipsychotic API, Anti Inflammatory and Immunosuppressant API.
Who are the key members and board of directors at A. R. Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kallam Chaitanya  | Director | 23-Aug-2007 | Current |
| Kallam Subbareddy | Director | 23-Aug-2007 | Current |
Financial of A. R. Life Sciences.
A. R. Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.95% decrease. The company also saw a slight improvement in profitability, with a 9.12% increase in profit. The company's net worth Soared by an impressive increase of 29.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A. R. Life Sciences?
In 2022, A. R. Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2022 | ₹5.70 Cr | Open |
Hdfc Bank Limited Creation Date: 25 Mar 2021 | ₹1.96 M | Open |
Others Creation Date: 21 Jul 2020 | ₹35.00 Cr | Open |
How Many Employees Work at A. R. Life Sciences?
A. R. Life Sciences has a workforce of 308 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A. R. Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A. R. Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
